drugset / Trial / NCT00004204

Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00004204 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of temozolomide in treating patients who have recurrent or progressive malignant glioma.

Timeline

Start
2000-02
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Temozolomide Small molecule — Oral